{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:51:09Z","timestamp":1757703069516},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00535-008-2186-5","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T14:27:50Z","timestamp":1215095270000},"page":"448-456","source":"Crossref","is-referenced-by-count":8,"title":["A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Michio","family":"Hongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Haruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,4]]},"reference":[{"issue":"Suppl2","key":"2186_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.44.2008.S1","volume":"44","author":"J. Dent","year":"1999","unstructured":"Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management\u2014the Genval Workshop Report. Gut 1999;44Suppl 2:S1\u2013S16.","journal-title":"Gut"},{"key":"2186_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365529309098350","volume":"199","author":"E. Dimenas","year":"1993","unstructured":"Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scand J Gastroenterol Suppl 1993;199:18\u201321.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2186_CR3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(97)00354-9","volume":"104","author":"D.A. Revicki","year":"1998","unstructured":"Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252\u2013258.","journal-title":"Am J Med"},{"key":"2186_CR4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00019053-200321110-00002","volume":"21","author":"M. Prasad","year":"2003","unstructured":"Prasad M, Rentz AM, Revicki DA. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life. Pharmacoeconomics 2003;21:769\u2013790.","journal-title":"Pharmacoeconomics"},{"key":"2186_CR5","first-page":"19","volume":"30","author":"I. Wiklund","year":"1998","unstructured":"Wiklund I, Bardhan KD, Muller-Lissner S, Bigard MA, Bianchi Porro G, Ponce J, et al. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. Ital J Gastroenterol Hepatol 1998;30:19\u201327.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"2186_CR6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","volume":"18","author":"M. Kulig","year":"2003","unstructured":"Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease\u2014an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767\u2013776.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.37.4.457","volume":"37","author":"G. Shi","year":"1995","unstructured":"Shi G, Bruley des Varannes S, Scarpignato C, Rhun ML, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995;37:457\u2013464.","journal-title":"Gut"},{"key":"2186_CR8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"L.R. Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis; clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172\u2013180.","journal-title":"Gut"},{"key":"2186_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","volume":"17","author":"S.D. Martinez","year":"2003","unstructured":"Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD)\u2014acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537\u2013545.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3Suppl","key":"2186_CR10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9270(03)00009-1","volume":"98","author":"R. Fass","year":"2003","unstructured":"Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003;98(3 Suppl):S2\u2013S7.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl1","key":"2186_CR11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2036.2004.01990.x","volume":"20","author":"H. Miwa","year":"2004","unstructured":"Miwa H, Minoo T, Hojo M, Yaginuma R, Nagahara A, Kawabe M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther 2004;20Suppl 1:112\u2013117.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.41.4.452","volume":"41","author":"Y. Kinoshita","year":"1997","unstructured":"Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997;41:452\u2013458.","journal-title":"Gut"},{"key":"2186_CR13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00535-004-1421-y","volume":"39","author":"M. Hongo","year":"2004","unstructured":"Hongo M. Reflux esophagitis and Helicobacter pylori: East and West. J Gastroenterol 2004;39:909\u2013910.","journal-title":"J Gastroenterol"},{"key":"2186_CR14","first-page":"125","volume":"33","author":"H. Tahir","year":"1984","unstructured":"Tahir H, Sumii K, Haruma K, Tari A, Uemura N, Shimizu H, et al. A statistical evaluation on the age and sex distribution of basal serum gastrin and gastric acid secretion in subjects with or without peptic ulcer disease. Hiroshima J Med Sci 1984;33:125\u2013130.","journal-title":"Hiroshima J Med Sci"},{"key":"2186_CR15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0016-5085(88)80008-8","volume":"95","author":"M. Feldman","year":"1988","unstructured":"Feldman M, Richardson CT, Lam SK, Samloff IM. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in occidental and oriental duodenal ulcer patients. Gastroenterology 1988;95:630\u2013635.","journal-title":"Gastroenterology"},{"key":"2186_CR16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0016-5085(91)90724-Y","volume":"101","author":"M. Goldschmiedt","year":"1991","unstructured":"Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991;101:977\u2013990.","journal-title":"Gastroenterology"},{"key":"2186_CR17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1572-0241.2005.40966.x","volume":"100","author":"Y. Fujiwara","year":"2005","unstructured":"Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754\u2013758.","journal-title":"Am J Gastroenterol"},{"key":"2186_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1746.2004.03521.x","volume":"20","author":"Y. Fujiwara","year":"2005","unstructured":"Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol 2005;20:26\u201329.","journal-title":"J Gastroenterol Hepatol"},{"key":"2186_CR19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/00365520510023260","volume":"40","author":"I. Mishima","year":"2005","unstructured":"Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005\u20131009.","journal-title":"Scand J Gastroenterol"},{"key":"2186_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2005.02467.x","volume":"21","author":"T. Wada","year":"2005","unstructured":"Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, et al. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomizedcontrolled study of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;21:2\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.1997.300000.x","volume":"11","author":"J.S. Arnestad","year":"1997","unstructured":"Arnestad JS, Kleveland PM, Waldum HL. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity. Aliment Pharmacol Ther 1997;11:355\u2013358.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.1997.00264.x","volume":"11","author":"H. Hedenstrom","year":"1997","unstructured":"Hedenstrom H, Alm C, Kraft M, Grahnen A. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Aliment Pharmacol Ther 1997;11:1137\u20131141.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1365-2036.1999.00587.x","volume":"13","author":"R.M. Khoury","year":"1999","unstructured":"Khoury RM, Katz PO, Castell DO. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther 1999;13:1211\u20131214.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3Suppl","key":"2186_CR24","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0002-9270(03)00013-3","volume":"98","author":"P. Bytzer","year":"2003","unstructured":"Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003;98(3 Suppl):S31\u2013S39.","journal-title":"Am J Gastroenterol"},{"key":"2186_CR25","first-page":"CD003245","volume":"2","author":"C. Donnellan","year":"2005","unstructured":"Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005;2:CD003245.","journal-title":"Cochrane Database Syst Rev"},{"key":"2186_CR26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00535-007-2022-3","volume":"42","author":"T. Joh","year":"2007","unstructured":"Joh T, Miwa H, Higuchi K, Shimatani T, Manabe N, Adachi K, et al. Validity of endoscopic classification of nonerosive reflux disease. J Gastroenterol 2007;42:444\u2013449.","journal-title":"J Gastroenterol"},{"key":"2186_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2036.2007.03350.x","volume":"26","author":"H. Miwa","year":"2007","unstructured":"Miwa H, Sasaki M, Furuta T, Koike T, Habu Y, Ito M, et al. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther 2007;26:69\u201377.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR28","first-page":"1883","volume":"24","author":"O. Ebi","year":"1997","unstructured":"Ebi O. Implementation of new Japanese GCP and the quality of clinical trials\u2014from the standpoint of the pharmaceutical industry (in Japanese with English abstract). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 1997;24:1883\u20131891.","journal-title":"Gan To Kagaku Ryoho (Jpn J Cancer Chemother)"},{"key":"2186_CR29","first-page":"1459","volume":"62","author":"Y. Hoshihara","year":"2004","unstructured":"Hoshihara Y. Endoscopic findings of GERD (in Japanese with English abstract). Nippon Rinsho (Jpn J Clin Med) 2004;62:1459\u20131464.","journal-title":"Nippon Rinsho (Jpn J Clin Med)"},{"key":"2186_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2005.02469.x","volume":"21","author":"T. Nakamura","year":"2005","unstructured":"Nakamura T, Shirakawa K, Masuyama H, Sugaya H, Hiraishi H, Terano A. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005;21:19\u201326.","journal-title":"Aliment Pharmacol Ther"},{"key":"2186_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-006-1775-4","volume":"41","author":"M. Hongo","year":"2006","unstructured":"Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006;41:95\u201399.","journal-title":"J Gastroenterol"},{"key":"2186_CR32","first-page":"CD002095","volume":"3","author":"B. Pinxteren van","year":"2006","unstructured":"van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006;3:CD002095.","journal-title":"Cochrane Database Syst Rev"},{"key":"2186_CR33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2036.1999.00558.x","volume":"13","author":"J.E. Richter","year":"1999","unstructured":"Richter JE, Kovacs TOG, Greski-Rose PA, Huang B, Fisher R. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 1999;13:795\u2013804.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2Suppl1","key":"2186_CR34","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","volume":"118","author":"M.M. Wolfe","year":"2000","unstructured":"Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000;118(2 Suppl 1):S9\u2013S31.","journal-title":"Gastroenterology"},{"key":"2186_CR35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.24.4.270","volume":"24","author":"T. Lind","year":"1983","unstructured":"Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole\u2014a gastric proton pump inhibitor\u2014on pentagastrin stimulated acid secretion in man. Gut 1983;24:270\u2013276.","journal-title":"Gut"},{"issue":"Suppl108","key":"2186_CR36","first-page":"105","volume":"20","author":"C. Cederberg","year":"1985","unstructured":"Cederberg C, Ekenved G, Lind T, Olbe L. Acid inhibitory characteristics of omeprazole in man. Scand J Gastroenterol 1985;20Suppl 108:105\u2013112.","journal-title":"Scand J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-008-2186-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2186-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:34:15Z","timestamp":1559097255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-008-2186-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["2186"],"URL":"https:\/\/doi.org\/10.1007\/s00535-008-2186-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}